The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Is BPC 157 Banned? Oral vs. Injectable Forms Explained The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review